Elevation of plasma soluble amyloid precursor protein beta in Alzheimer’s disease

•Plasma sAPPβ levels is higher in Alzheimer’s disease patients than in controls.•Plasma sAPPβ levels tends to increase with increasing cognitive impairment.•sAPPα and sAPPβ in plasma have a strong positive correlation, which is stronger in MCI and AD than in controls. Beta-amyloid is considered to b...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Archives of gerontology and geriatrics 2020-03, Vol.87, p.103995-103995, Article 103995
Hauptverfasser:	Yun, Sang-Moon, Cho, Sun-Jung, Jo, Chulman, Park, Moon Ho, Han, Changsu, Koh, Young Ho
Format:	Artikel
Sprache:	eng
Schlagworte:	Alzheimer’s disease (AD) Cognitive impairment Plasma biomarker Soluble amyloid precursor proteins alpha (sAPPα) Soluble amyloid precursor proteins beta (sAPPβ)
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!